Anikó Pálfi

Anikó Pálfi

Company: Heidelberg Pharma Research GmbH

Job title: Director, Biochemistry & Cell Biology

Seminars:

Targeted Cancer Therapy for Patients With 17p Deletion 2:00 pm

Discussing Del(17p) as a potential platform-wide predictive biomarker for amanitin based ADCs Highlighting superior efficacy of amanitin based ADCs in cancer models with 17p loss Outlining the expedited clinical development of HDP-101 for Del(17p) patientsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.